The maker of Marlboro cigarettes is gaining a 'unique entry into cannabis' (MO, CRON)

pulse

December 10, 2018 4:51 PM

Cronos can leverage Altria's expertise to focus on ingredient composition without reliance on a massive cultivation infrastructure, an analyst said.

null

Cronos has a focus on rare cannabinoids, which has greater potential than just focusing on the two most known cannabinoids, Azer added.
Cronos can leverage Altria's expertise to focus on ingredient composition without reliance on a massive cultivation infrastructure, Azer said.
Watch

Marlboro cigarette maker Altria's

pulse

Enhance Your Pulse News Experience!

Get rewards worth up to $20 when selected to participate in our exclusive focus group. Your input will help us to make informed decisions that align with your needs and preferences.

I've got feedback!

JOIN OUR PULSE COMMUNITY!

Unblock notifications in browser settings.

Eyewitness? Submit your stories now via social or:

Email: eyewitness@pulse.ng